Resultats de la cerca - Jeffrey H. Lipton

Refinar resultats
  1. 1
    Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance

    Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance per Nazanin Aghel, Diego Delgado, Jeffrey H. Lipton

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Treatment‐free remission with first‐ and second‐generation tyrosine kinase inhibitors

    Treatment‐free remission with first‐ and second‐generation tyrosine kinase inhibitors per Jorge E. Cortés, Delphine Réa, Jeffrey H. Lipton

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas.

    Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. per Kevin Hardy, Jeffrey H. Lipton, M. O. Scase, David Foster, J. H. B. Scarpello

    Publicat 1992
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis

    Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis per Elena Kolomietz, Jaudah Al‐Maghrabi, Shawn Brennan, Jana Karásková, Solomon Minkin, Jeffrey H. Lipton, Jeremy A. Squire

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients

    A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients per Yoichiro Natori, Atul Humar, Jeffrey H. Lipton, D D Kim, Peter D. Ashton, Katja Höschler, Deepali Kumar

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option

    Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option per Jeffrey H. Lipton, Tim H. Brümmendorf, Carlo Gambacorti‐Passerini, Valentín García‐Gutiérrez, Michael W. Deininger, Jorge E. Cortés

    Publicat 2022
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Management of chronic myeloid leukemia in 2023 – common ground and common sense

    Management of chronic myeloid leukemia in 2023 – common ground and common sense per Jayastu Senapati, Koji Sasaki, Ghayas C. Issa, Jeffrey H. Lipton, Jerald P. Radich, Elias Jabbour, Hagop M. Kantarjian

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia

    Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia per Dong Hwan Kim, Lakshmi Sriharsha, Wei Xu, Suzanne Kamel‐Reid, Xiangdong Liu, Katherine Siminovitch, Hans A. Messner, Jeffrey H. Lipton

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, and Clinical Significance

    Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, and Clinical Significance per Deborah Siegal, Anne Keller, Wei Xu, Sandeep Bhuta, Dong Hwan Kim, John Kuruvilla, Jeffrey H. Lipton, Hans A. Messner, Vikas Gupta

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia

    Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia per Dong H. Kim, Suzanne Kamel‐Reid, Hong Chang, Robert Sutherland, Chang Wook Jung, H.-J. Kim, J.-J. Lee, Jeffrey H. Lipton

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Similar Outcomes of Cryopreserved Allogeneic Peripheral Stem Cell Transplants (PBSCT) Compared to Fresh Allografts

    Similar Outcomes of Cryopreserved Allogeneic Peripheral Stem Cell Transplants (PBSCT) Compared to Fresh Allografts per Dong Hwan Kim, Nazir Jamal, R Saragosa, David Loach, Janice Wright, Vikas Gupta, John Kuruvilla, Jeffrey H. Lipton, Mark D. Minden, Hans A. Messner

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation

    A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute le... per Kathryn E. Webert, Richard J. Cook, Stephen Couban, Julie Carruthers, Ker‐Ai Lee, Morris A. Blajchman, Jeffrey H. Lipton, Joseph Brandwein, Nancy M. Heddle

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase

    BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase per Timothy P. Hughes, Giuseppe Saglio, Alfonso Quintás‐Cardama, Michael J. Mauro, D-W Kim, Jeffrey H. Lipton, M. Brigid Bradley‐Garelik, Jon Ukropec, Andreas Hochhaus

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Validation of National Institutes of Health Global Scoring System for Chronic Graft-Versus-Host Disease (GVHD) According to Overall and GVHD-Specific Survival

    Validation of National Institutes of Health Global Scoring System for Chronic Graft-Versus-Host Disease (GVHD) According to Overall and GVHD-Specific Survival per Joon Ho Moon, Sang Kyun Sohn, Anna Lambie, Laura Ellis, Nada Hamad, Jieun Uhm, Vikas Gupta, Jeffrey H. Lipton, Hans A. Messner, John Kuruvilla, Dennis Kim

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies

    Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploi... per Arjun Law, María Queralt Salas, Wilson Lam, Fotios V. Michelis, Santhosh Thyagu, Dennis Dong Hwan Kim, Jeffrey H. Lipton, Rajat Kumar, Hans A. Messner, Auro Viswabandya

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia

    Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia per Timothy P. Hughes, Pierre Laneuville, Philippe Rousselot, David S. Snyder, Delphine Réa, Neil P. Shah, Dávid Paár, Elisabetta Abruzzese, Andreas Hochhaus, Jeffrey H. Lipton, Jorge E. Cortés

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

    Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease per Andrew J. Ullmann, Jeffrey H. Lipton, David H. Vesole, Pranatharthi Chandrasekar, Amelia Langston, Stefano Tarantolo, Hildegard Greinix, Wellington Azevedo, Vijay Reddy, Navdeep Boparai, Lisa D. Pedicone, Hernando Patino, Simon Durrant

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms

    Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms per Theodore A. Kennedy, Eshetu G. Atenafu, Hans A. Messner, Kenneth J. Craddock, Joseph Brandwein, Jeffrey H. Lipton, Mark D. Minden, Aaron D. Schimmer, Andre C. Schuh, Karen Yee, Vikas Gupta

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy

    Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy per Tae‐Hyung Kim, Marc S. Tyndel, Hyeoung Joon Kim, Jae-Sook Ahn, Seung Hyun Choi, Hee Jeong Park, Yeo‐Kyeoung Kim, Soo Young Kim, Jeffrey H. Lipton, Zhaolei Zhang, Dennis Dong Hwan Kim

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen

    Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen per John M. Storring, Mark D. Minden, Susan Kao, Vikas Gupta, Andre C. Schuh, Aaron D. Schimmer, Karen Yee, Suzanne Kamel‐Reid, Hong Chang, Jeffrey H. Lipton, Hans A. Messner, Wei Xu, Joseph Brandwein

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: